Diet in children with phenylketonuria and risk of cardiovascular disease: A narrative overview
- PMID: 26708644
- DOI: 10.1016/j.numecd.2015.10.005
Diet in children with phenylketonuria and risk of cardiovascular disease: A narrative overview
Abstract
Aims: The aim of this paper is to review the possible relationship of restricted phenylalanine (Phe) diet, a diet primarily comprising low-protein foods and Phe-free protein substitutes, with major cardiovascular risk factors (overweight/obesity, blood lipid profile, plasma levels of homocysteine, adiponectin and free asymmetric dimethylarginine (ADMA), oxidative stress and blood pressure) in PKU children.
Data synthesis: In PKU children compliant with diet, blood total cholesterol, low-density lipoprotein cholesterol (LDL-C), plasma ADMA levels and diastolic pressure were reported to be lower and plasma adiponectin levels to be higher compared to healthy controls. No difference was observed in overweight prevalence and in high-density lipoprotein cholesterol (HDL-C) levels. Inconsistent results were found for plasma homocysteine levels and antioxidant status.
Conclusions: PKU children compliant with diet seem to display non-different cardiovascular risks compared with the healthy population. Well-designed longitudinal studies are required to clarify the potential underlying mechanisms associated with PKU and cardiovascular risk factors.
Keywords: Cardiovascular risk; Lipid profile; Nutrition; Obesity; PKU diet; Phenylketonuria.
Copyright © 2015 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.Orphanet J Rare Dis. 2016 Sep 9;11(1):123. doi: 10.1186/s13023-016-0508-x. Orphanet J Rare Dis. 2016. PMID: 27612877 Free PMC article.
-
Increased plasma adiponectin concentrations in poorly controlled patients with phenylketonuria normalize with a strict diet: evidence for catecholamine-mediated adiponectin regulation and a complex effect of phenylketonuria diet on atherogenesis risk factors.Metabolism. 2005 Oct;54(10):1350-5. doi: 10.1016/j.metabol.2005.04.025. Metabolism. 2005. PMID: 16154435
-
Free asymmetric dimethylarginine (ADMA) is low in children and adolescents with classical phenylketonuria (PKU).J Inherit Metab Dis. 2012 Sep;35(5):817-21. doi: 10.1007/s10545-011-9448-8. Epub 2012 Jan 31. J Inherit Metab Dis. 2012. PMID: 22290024
-
Optimal serum phenylalanine for adult patients with phenylketonuria.Mol Genet Metab. 2013 Dec;110(4):424-30. doi: 10.1016/j.ymgme.2013.09.007. Epub 2013 Sep 20. Mol Genet Metab. 2013. PMID: 24094552 Review.
-
Is the Phenylalanine-Restricted Diet a Risk Factor for Overweight or Obesity in Patients with Phenylketonuria (PKU)? A Systematic Review and Meta-Analysis.Nutrients. 2021 Sep 28;13(10):3443. doi: 10.3390/nu13103443. Nutrients. 2021. PMID: 34684443 Free PMC article.
Cited by
-
Growth Parameters and Prevalence of Obesity in PKU Patients and Peers: Is This the Right Comparison?Pediatr Rep. 2024 Oct 16;16(4):892-901. doi: 10.3390/pediatric16040076. Pediatr Rep. 2024. PMID: 39449403 Free PMC article.
-
Low bone mineralization in phenylketonuria may be due to undiagnosed metabolic acidosis.Mol Genet Metab Rep. 2023 Aug 9;36:100998. doi: 10.1016/j.ymgmr.2023.100998. eCollection 2023 Sep. Mol Genet Metab Rep. 2023. PMID: 37600232 Free PMC article.
-
Overweight/obesity in adolescents with phenylketonuria: protective and predisposing factors.J Pediatr (Rio J). 2022 Jan-Feb;98(1):104-110. doi: 10.1016/j.jped.2021.04.009. Epub 2021 Jun 16. J Pediatr (Rio J). 2022. PMID: 34144002 Free PMC article.
-
Antioxidant and Anti-Inflammatory Activity of a New Formulation of Slow-Release Amino Acids in Human Intestinal Caco-2 Cells.Antioxidants (Basel). 2025 Feb 26;14(3):271. doi: 10.3390/antiox14030271. Antioxidants (Basel). 2025. PMID: 40227204 Free PMC article.
-
Asymmetric dimethylarginine as a potential biomarker for management and follow-up of phenylketonuria.Eur J Pediatr. 2019 Jun;178(6):903-911. doi: 10.1007/s00431-019-03365-0. Epub 2019 Apr 2. Eur J Pediatr. 2019. PMID: 30941500
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical